Regenerative Injection denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for regenerative injection are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Your Regenerative Injection for Exceeding Quantity Limits

Cigna's quantity-limit denial for a regenerative injection means your claim or authorization request exceeds the number of injections — per treatment site, per body region, or per time period — that Cigna's medical policy permits. These limits are set by Cigna's internal coverage criteria, not by FDA labeling, and they may not reflect your individual clinical needs. Quantity-limit denials are routinely appealed successfully when a prescriber documents why the standard limit is clinically insufficient for the specific patient's condition, severity, or treatment response.

## Your Right to Appeal

• Internal appeal: File a written appeal within the timeframe stated on your denial letter. Request the specific quantity-limit language from Cigna's medical policy and the rationale for the limit.
• External review (ACA §2719): If the internal appeal is denied, request IRO external review — generally available within four months of your final internal denial. External reviewers apply current clinical standards; a prescriber's individualized rationale for exceeding a plan limit carries significant weight.
• Expedited review: Available for urgent cases.
• ERISA §503: Employer-sponsored plan members retain full-and-fair review rights.

## Documentation to Gather

1. Clinical justification for additional quantity: Your prescriber's documentation of why the standard limit does not meet your clinical needs — this may include the specific anatomical sites involved, the severity and extent of the condition, prior response to treatment, and the treatment plan rationale. 2. Treatment response records: Documentation of how prior injections performed — functional improvement measurements, pain assessments, and clinical notes from follow-up visits — demonstrating that the treatment is producing benefit and that additional administrations are clinically warranted, not redundant. 3. Diagnosis and severity records: Current imaging, examination findings, and assessments documenting the scope and severity of the condition. 4. Prescriber medical-necessity letter: A letter addressing Cigna's quantity-limit criteria directly, explaining the individualized clinical basis for the requested quantity, and citing the applicable clinical guideline organization's recommendations.

## Criteria-Mapping Strategy

Obtain the exact language of Cigna's quantity limit from the applicable medical policy. Identify whether the limit is absolute or whether exceptions are contemplated. Many policies include language allowing for additional quantities when clinically justified — if so, your appeal should map directly to those exception criteria. If the policy contains no exception pathway, your external-review argument is that a blanket numerical limit, applied without regard to individual clinical circumstances, does not constitute a full-and-fair review of medical necessity. Document each additional injection requested with a specific clinical rationale tied to chart findings.